Mucosolvan Hustensaft-Portionsbeutel (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosolvan Hustensaft-Portionsbeutel, is a mucolytic presented as an oral solution in portion sachets for oral use. It helps relieve cough with thick mucus and supports clearance of secretions in respiratory conditions for both adults and children, and improves breathing comfort.

GNH USA supplies Mucosolvan Hustensaft-Portionsbeutel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. GNH USA’s network ensures timely delivery and regulatory compliance across EU and other markets.

Ambroxol Hydrochloride is a mucolytic agent used in the management of respiratory conditions characterized by thick, viscous secretions.

- Cough with thick mucus: loosens and thins mucus to facilitate expectoration. - Acute bronchitis: improves sputum clearance and reduces cough duration. - Respiratory tract infections: aids mucus removal and supports breathing comfort.

Adverse reactions to Ambroxol Hydrochloride are generally mild, but some patients may experience side effects.

Common Side Effects: - Taste alteration: temporary change in taste perception. - Nausea: mild stomach upset. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling. - Angioedema: rapid swelling of face, lips, or throat. - Hepatic enzyme elevation: increased liver function test values.

When using Ambroxol Hydrochloride, certain precautions should be observed to ensure safe and effective therapy.

- Dosage adjustment: consider reduced dose in patients with renal impairment. - Caution in asthma: monitor for bronchospasm in asthmatic individuals. - Hypersensitivity: avoid use in persons with known allergy to ambroxol or related compounds. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Ambroxol Hydrochloride may interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent use with other mucolytics: risk of excessive thinning of mucus. - Combination with antitussives containing codeine: may diminish mucolytic effectiveness.

Moderate Interactions (Monitor Closely): - Bronchodilators (e.g., salbutamol): may enhance bronchodilation, monitor respiratory response. - Antihistamines: possible increase in sedation. - CYP450 inhibitors (e.g., erythromycin): may raise ambroxol plasma levels.